Antipsychotic Medication Could Be Hazardous For Dementia Patients

.

Antipsychotic Medication Could Be Hazardous For Dementia Patients

A recent research, conducted by the US researchers, has found that prescribing antipsychotic medication to dementia patients could prove hazardous for their health as it could put them a step closer to death.

The findings of the research have been published on the website of British Medical Journal. According to the researchers, the antipsychotic medication leaves strong sedative effect on the patients, which could be harmful for the dementia patients.

The medical experts while acknowledging the finding of the researchers said that alternative drugs of antipsychotics should be prescribed to the dementia patients. The research was initiated in 2009, which looked over the health of 180,000 dementia patients who were taking antipsychotic medication.

During the research, it was found that the medication led to 1,800 deaths in total. It has come to light that some of the antipsychotic medications are highly dangerous for the dementia patients. Risperidone as compared to other antipsychotic medications is safer and thus can be prescribed.

While concluding the study, the researchers said, "The data suggest that the risk of mortality with these drugs is generally increased with higher doses and seems to be highest for haloperidol and least for quetiapine".

However, the medical experts said that it is too early to say that the alleged medications cause death to dementia patients as in some cases the drugs have actually helped in improving the lives of many. Further research over the medications has been called for.

But, the Department of Health has asked the health professionals to lower the dosage of the medication unless and until the mysteries behind the link between death and the antipsychotic medication aren't unveiled. A review over the antipsychotic medication has also been called by the Dementia Action Alliance.


Latest News

Rise in Russian Arms Sales In spite of a Drop Globally
PetSmart Sells itself with an $8.3Billion Deal
Falling Oil Prices Result in a Drop in Stocks
Shares of Amaya Fall Due to Probe Conducted by Securities Regulators
Americans Consumers Display Confidence In the Market with Gain in Sales
It’s Time to Hurry Up to Enrol in the First Phase of Affordable Care Act Health
After Merger with Alliance Boots,	Walgreen CEO will Retire
Falling Fuel Prices Lift Airline Profits But No Respite in Fares Expected
Citigroup to Pay Likely $2.7B as Legal Charge
Michael Jeffries Retires as the CEO of Abercrombie & Fitch
Deutsche Bank in Trouble Again in the U.S. for Alleged Tax Scheme
Popular Demand Brings French Toast Crunch Back on the Shelves